Caribou Biosciences (CRBU) Free Cash Flow Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 88.70% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 66.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.98% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 137.65% |
| 10 | Caribou Biosciences | 232.46 Mn | 114.84 Mn | - | 26.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.71% |
| Dec 31, 2025 | 42.50% |
| Sep 30, 2025 | 23.00% |
| Jun 30, 2025 | 8.04% |
| Mar 31, 2025 | 3.19% |
| Dec 31, 2024 | -66.63% |
| Sep 30, 2024 | -32.71% |
| Jun 30, 2024 | -78.29% |
| Mar 31, 2024 | -28.33% |
| Dec 31, 2023 | 0.25% |
| Sep 30, 2023 | 6.09% |
| Jun 30, 2023 | 16.41% |
| Mar 31, 2023 | -30.90% |
| Dec 31, 2022 | 2.28% |
| Sep 30, 2022 | -65.86% |
| Jun 30, 2022 | -27.35% |
| Mar 31, 2022 | -211.65% |
| Dec 31, 2021 | -172.42% |
| Sep 30, 2021 | -82.62% |